マウスの1型糖尿病は,インタールイキン-1受容体と,染色体1のLsh/Ity/Bcg遺伝子と関連している
R J Cornall1, J B Prins, J A Todd
1Nuffield Department of Surgery, John Radcliffe Hospital, Headington, Oxford UK.
Nature
|September 19, 1991
まとめ
研究者らは,マウスで新しい糖尿病感受性遺伝子,IDD-5をマッピングした. この発見は,第1型糖尿病および関連する自己免疫疾患に寄与する遺伝的要因の理解を進めています.
科学分野:
- 免疫学 免疫学とは
- 遺伝学 遺伝学とは
- エンドクリノロジー エンドクリノロジー
背景:
- 1型糖尿病は,遺伝子と環境の両方の原因で,臓のβ細胞に影響する自己免疫疾患です.
- 非肥満糖尿病 (NOD) のマウスは,ヒトの1型糖尿病と遺伝的および免疫病理学的類似性を共有しています.
- 以前の研究では,マウスで3つの糖尿病感受性遺伝子 (Idd-1から -4) を特定しました.
研究 の 目的:
- 非肥満糖尿病 (NOD) のマウスの新型糖尿病感受性遺伝子をマッピングする.
- マッピングされた地域内の潜在的な候補遺伝子を特定するために.
- 自己免疫性糖尿病の遺伝的基礎をさらに解明するために.
主な方法:
- NODマウスにおける糖尿病感受性ロシウムの遺伝子マッピング.
- マウス染色体1の候補遺伝子の分析.
- 免疫機能における潜在的な役割について,マッピングされた領域内の既知の遺伝子のレビュー.
主要な成果:
- 新しい糖尿病感受性ロカス,Idd-5は,マウス染色体1の近接領域にマッピングされました.
- この領域には少なくとも2つの候補遺伝子が含まれています:インタールイキン-1受容体遺伝子とLsh/Ity/Bcg.
- Idd-1の位置は,ヒトのHLA-DQB1.1の同型である免疫反応I-Aβ遺伝子と関連しています.
結論:
- Idd-5の識別は,自己免疫性糖尿病の遺伝学を理解するための新しいターゲットを提供します.
- Idd-5ロカス内の候補遺伝子は,インタールイキン-1受容体やLsh/Ity/Bcgなど,さらなる調査が必要である.
- マウスにおけるこれらの遺伝因子を理解することで,ヒトの1型糖尿病についての洞察が得られます.
関連する概念動画
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...


